Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11675-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11675-1-AP, RRID:AB_2197436
- Product name
- SUGT1 antibody
- Antibody type
- Polyclonal
- Description
- SUGT1 antibody (Cat. #11675-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Mechanism by which SUGT1 downregulates FH to promote proliferation and migration in serous ovarian cancer.
SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer.
SUGT1 regulates the progression of ovarian cancer through the AKT/PI3K/mTOR signaling pathway.
HSF1 Protects Sepsis-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome Activation.
Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90.
Calcyclin Binding Protein/Siah-1 Interacting Protein Is a Hsp90 Binding Chaperone.
The oncogenic role of the cochaperone Sgt1.
Overexpression of SUGT1 in human colorectal cancer and its clinicopathological significance.
Mu T, Ren B, Kuang Z, He R, Rui B, Yang Y, Liu Y, Geng D, Zhang Y, Wang M
Journal of ovarian research 2025 Jul 29;18(1):168
Journal of ovarian research 2025 Jul 29;18(1):168
SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer.
Ge L, Liu X, Zhang L, Zhang J, Song G
European journal of medical research 2025 Jan 10;30(1):21
European journal of medical research 2025 Jan 10;30(1):21
SUGT1 regulates the progression of ovarian cancer through the AKT/PI3K/mTOR signaling pathway.
Ke M, Xu J, Ouyang Y, Chen J, Yuan D, Guo T
Translational oncology 2024 Nov;49:102088
Translational oncology 2024 Nov;49:102088
HSF1 Protects Sepsis-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome Activation.
Shi X, Li T, Liu Y, Yin L, Xiao L, Fu L, Zhu Y, Chen H, Wang K, Xiao X, Zhang H, Tan S, Tan S
Frontiers in immunology 2022;13:781003
Frontiers in immunology 2022;13:781003
Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90.
Xu G, Fu S, Zhan X, Wang Z, Zhang P, Shi W, Qin N, Chen Y, Wang C, Niu M, Guo Y, Wang J, Bai Z, Xiao X
JCI insight 2021 Jan 25;6(2)
JCI insight 2021 Jan 25;6(2)
Calcyclin Binding Protein/Siah-1 Interacting Protein Is a Hsp90 Binding Chaperone.
Góral A, Bieganowski P, Prus W, Krzemień-Ojak Ł, Kądziołka B, Fabczak H, Filipek A
PloS one 2016;11(6):e0156507
PloS one 2016;11(6):e0156507
The oncogenic role of the cochaperone Sgt1.
Ogi H, Sakuraba Y, Kitagawa R, Xiao L, Shen C, Cynthia MA, Ohta S, Arnold MA, Ramirez N, Houghton PJ, Kitagawa K
Oncogenesis 2015 May 18;4(5):e149
Oncogenesis 2015 May 18;4(5):e149
Overexpression of SUGT1 in human colorectal cancer and its clinicopathological significance.
Iwatsuki M, Mimori K, Sato T, Toh H, Yokobori T, Tanaka F, Ishikawa K, Baba H, Mori M
International journal of oncology 2010 Mar;36(3):569-75
International journal of oncology 2010 Mar;36(3):569-75
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Jurkat cells were subjected to SDS PAGE followed by western blot with 11675-1-AP(SUGT1 antibody) at dilution of 1:300
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The SUGT1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human SUGT1. This antibody recognizes human,mouse,rat antigen. The SUGT1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
